Has Eytan Debbi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $167,562 in general payments to Eytan Debbi, MD across 223 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eytan Debbi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eytan Debbi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eytan Debbi, MD

Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1205324423

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $108,407 of the $167,562 with a category attached, or 64.7%. Medical Device Business Services, Inc. accounts for 66.2% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $73,714, more than ten times the $2,677 reported in 2019.

$167,562in general payments, 2019–2025

Across 223 payments — averaging $751.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$111K
Think Surgical, Inc.$27K
Depuy Synthes Products, Inc.$11K
Ortho Development Corporation$8K
Stryker$6K
Johnson & Johnson$2K
plus $2K from 11 others

What the payments were for

Consulting fees$108,40765%
Speaking & faculty fees$5,0003%
Travel & lodging$39,41924%
Food & beverage$9,8546%
Education$4,7693%
Gifts$1140%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	101	$110,872
Think Surgical, Inc.	44	$26,694
Depuy Synthes Products, Inc.	7	$11,118
Ortho Development Corporation	10	$8,145
Stryker	13	$6,360
Johnson & Johnson(2 entities)	25	$2,002
Smith+Nephew	6	$562
Synthes GmbH	2	$410
Zimmer Biomet	6	$336
UOC USA Inc	2	$246
Encore Medical, LP	1	$160
Next Science LLC	1	$159
Globus Medical	1	$148
Engage Uni, LLC	1	$114
Integra Lifesciences Corporation	1	$105
Medacta USA, Inc.	1	$98
Molnlycke Health Care US, LLC	1	$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Velys$71,158
TMINI Miniature Robotic System$18,237
Tsolution One Surgical System$7,729
ATTUNE$5,691
INSIGNIA$4,570
ACTIS$4,332
MAKO$1,671
DJO SURGICAL$321
BKS TriMax$316
U2 TKA, Conformity, USTARII, U-Motion II$246
Persona$232
Journey II$171
LEGION TKS$171
REDAPT$171
CORI$171
Entrada Hip Stem$169
Balanced Knee Revision System$169
SurgX$159
Xperience$159
BlastX$159

How this compares

$167,562 in reported general payments places this provider in the 85th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$690,841

Medicare patients

735

Services billed

1,544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	22	$431
Meloxicam	92	$203
Oxycodone Hcl	24	$179
Gabapentin	16	$64
Amoxicillin	26	$52

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in New York

Seth JerabekNew York$7.1M
Jose RodriguezNew York$3.4M
Friedrich BoettnerNew York$2.9M
Jonathan VigdorchikNew York$2.3M
William LongNew York$1.5M
Peter SculcoNew York$1.5M
Roshan ShahNew York$1.3M
Herbert CooperNew York$1.3M
Matthew AustinNew York$986K
Patrick MeereNew York$191K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →